NASDAQ$PHVS
Pharvaris NV · Q2 2026 earnings
Q2 2026 earnings · · After market close · Investor relations
Reports in 4 weeks
Pharvaris hasn't published Q2 2026 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q1 2026
- Revenue
- —
- EPS
- -€0.60
Year-ago · Q2 2025 Q2 2025
- Revenue
- —
- EPS
- -€0.83
FY2026 consensus Analyst consensus
- Revenue
- $7.6M
- EPS
- -$3.07
Revenue & EPS history
Pharvaris · Revenue · Quarterly
$0
Q3 2025
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 13 quarterly earnings reports
+16.7%
Avg return
Earnings day
+16.1%
Avg return
5 days after
+27.4%
Avg return
30 days after
36%
5 / 14 earnings
Positive
+243.4%
Q3 2022
Best reaction
-10.4%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.4% | +1.5% | +7.3% | |
| Q3 2025 | +7.3% | +3.3% | +0.2% | |
| Q4 2024 | -10.4% | -9.2% | +29.0% | |
| Q3 2024 | +3.6% | +5.4% | -7.3% | |
| Q4 2023 | -3.6% | -12.9% | -7.3% | |
| Q3 2023 | +9.3% | +2.7% | +9.9% | |
| Q2 2023 | -3.9% | -1.4% | +11.6% | |
| Q4 2022 | -5.2% | -2.0% | +9.0% | |
| Q3 2022 | +243.4% | +241.4% | +376.1% | |
| Q2 2022 | -2.7% | -2.1% | -46.3% | |
| Q4 2021 | -0.8% | -0.4% | -1.1% | |
| Q3 2021 | -0.2% | -0.8% | -6.8% | |
| Q2 2021 | -2.4% | -1.8% | +18.0% | |
| Q1 2021 | +0.0% | +1.2% | -8.7% | |
| Q3 2020 | — | — | — | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — | |
| Q4 2019 | — | — | — | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro